Risk factors and incidence rate of complications originated as a consequence of the acute SARS-CoV-2 infection or the treatments performed. A longitudinal study in general medicine from March 15, 2020 to October 31, 2022 in Toledo, Spain
Article Sidebar
Main Article Content
Abstract
Background: The epidemiological data on complications originated as a consequence of the acute infection of COVID-19 or the treatments performed are not well known.
Objectives: To estimate the incidence rate and the risk factors of complications originating as a consequence of the acute infection of COVID-19 or the treatments performed in general practitioner consultation.
Methodology: A prospective study of patients with COVID-19 in a general practice setting in Toledo, Spain, from March 15, 2020, to October 31, 2022.
Results: 687 positive cases of acute COVID-19 were diagnosed. Of these, 36 (36% were women and 39% had >=65 years old) presented complications, which represents a gross incidence rate of 5%. In >=65 years old, the incidence rate was 23%. The incidence rate of complications was much higher in 2020 vs. 2021 and 2022 (21%, 5%, and 1% cases, respectively). The only statistically significant risk factors were aged > = 65 years (RR = 2.46), having presented moderate-severe severity of primary infection (RR = 14.54) having chronic diseases (RR = 3.11), and specifically of the circulatory system (RR = 1.98).
Conclusion: In the context of general medicine in Toledo (Spain) incidence rate of complications originated as a consequence of acute infection of COVID-19 or the treatments performed, was higher in cases with acute infection in 2020, and in >=65 years old, and are risk factors having presented moderate-severe severity of primary infection, having chronic diseases, and specifically of circulatory system, and being >= 65 years old.
Downloads
Article Details
Copyright (c) 2023 Turabian JL.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ; HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16. PMID: 32192578; PMCID: PMC7270045.
Godlee F. How can we manage covid fatigue? BMJ. 2021; 373: n1610. https://www.bmj.com/content/373/bmj.n1610?utm_source=etoc&utm_medium=email&utm_campaign=tbmj&utm_content=weekly&utm_term=20210625
Somersan-Karakaya S, Mylonakis E, Menon VP, Wells JC, Ali S, Sivapalasingam S, Sun Y, Bhore R, Mei J, Miller J, Cupelli L, Forleo-Neto E, Hooper AT, Hamilton JD, Pan C, Pham V, Zhao Y, Hosain R, Mahmood A, Davis JD, Turner KC, Kim Y, Cook A, Kowal B, Soo Y, DiCioccio AT, Geba GP, Stahl N, Lipsich L, Braunstein N, Herman GA, Yancopoulos GD, Weinreich DM; COVID-19 Phase 2/3 Hospitalized Trial Team. Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19. J Infect Dis. 2022 Dec 28;227(1):23-34. doi: 10.1093/infdis/jiac320. PMID: 35895508; PMCID: PMC9384575.
Fraser E. Persistent pulmonary disease after acute covid-19. BMJ. 2021 Jun 21;373:n1565. doi: 10.1136/bmj.n1565. PMID: 34154988.
Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021 Jun;594(7862):259-264. doi: 10.1038/s41586-021-03553-9. Epub 2021 Apr 22. PMID: 33887749.
Campillo S. The consequences that COVID-19 leaves in those who survive it in the ICU: kidney, neurological, cardiac and muscular damage. Xataka; 23 Abril. https://www.xataka.com/medicina-y-salud/sobrevivir-uci-covid-19-no-facil-tampoco-superar-secuelas-que-vienen-despues
Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. PMID: 32171076; PMCID: PMC7270627.
Servante J, Swallow G, Thornton JG, Myers B, Munireddy S, Malinowski AK, Othman M, Li W, O'Donoghue K, Walker KF. Haemostatic and thrombo-embolic complications in pregnant women with COVID-19: a systematic review and critical analysis. BMC Pregnancy Childbirth. 2021 Feb 5;21(1):108. doi: 10.1186/s12884-021-03568-0. PMID: 33546624; PMCID: PMC7863033.
Dessie ZG, Zewotir T. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis. 2021 Aug 21;21(1):855. doi: 10.1186/s12879-021-06536-3. PMID: 34418980; PMCID: PMC8380115.
Wolff D, Nee S, Hickey NS, Marschollek M. Risk factors for Covid-19 severity and fatality: a structured literature review. Infection. 2021 Feb;49(1):15-28. doi: 10.1007/s15010-020-01509-1. Epub 2020 Aug 28. PMID: 32860214; PMCID: PMC7453858.
Robitzski D. Doctors and Researchers Probe How COVID-19 Attacks the Heart. Experts have a decent grasp on how COVID-19 impacts cardiovascular health in the near term. The implications of long COVID, however, remain mysterious. The Scientist; 2022. Jan 12. https://www.the-scientist.com/news-opinion/doctors-and-researchers-probe-how-covid-19-attacks-the-heart-69592?utm_campaign=TS_DAILY_NEWSLETTER_2021&utm_medium=email&_hsmi=239866332&_hsenc=p2ANqtz-_KnRiqmHdTHteGzGKMclT6OAHSK7cV0nuoHjEmJOmpiecG8fcAv-gw_VYovOUv42eDFiWzq1so6-bFC5MeUEiRHo102w&utm_content=239866332&utm_source=hs_email
Sarfraz Z, Sarfraz A, Barrios A, Garimella R, Dominari A, Kc M, Pandav K, Pantoja JC, Retnakumar V, Cherrez-Ojeda I. Cardio-Pulmonary Sequelae in Recovered COVID-19 Patients: Considerations for Primary Care. J Prim Care Community Health. 2021 Jan-Dec;12:21501327211023726. doi: 10.1177/21501327211023726. PMID: 34096390; PMCID: PMC8188976.
Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, Haroon S, Price G, Davies EH, Nirantharakumar K, Sapey E, Calvert MJ; TLC Study Group. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021 Sep;114(9):428-442. doi: 10.1177/01410768211032850. Epub 2021 Jul 15. PMID: 34265229; PMCID: PMC8450986.
Salari N, Khodayari Y, Hosseinian-Far A, Zarei H, Rasoulpoor S, Akbari H, Mohammadi M. Global prevalence of chronic fatigue syndrome among long COVID-19 patients: A systematic review and meta-analysis. Biopsychosoc Med. 2022 Oct 23;16(1):21. doi: 10.1186/s13030-022-00250-5. PMID: 36274177; PMCID: PMC9589726.
Gao YD, Ding M, Dong X, Zhang JJ, Kursat Azkur A, Azkur D, Gan H, Sun YL, Fu W, Li W, Liang HL, Cao YY, Yan Q, Cao C, Gao HY, Brüggen MC, van de Veen W, Sokolowska M, Akdis M, Akdis CA. Risk factors for severe and critically ill COVID-19 patients: A review. Allergy. 2021 Feb;76(2):428-455. doi: 10.1111/all.14657. Epub 2020 Dec 4. PMID: 33185910.
Bianconi V, Cosentini E, Mannarino MR, Pirro M. Risk Factors of Developing COVID-19 and its Severe Course. In: Banach, M. (eds) Cardiovascular Complications of COVID-19. Contemporary Cardiology. Humana, Cham. 2022. https://doi.org/10.1007/978-3-031-15478-2_4. https://link.springer.com/chapter/10.1007/978-3-031-15478-2_4#citeas
Wu Z, McGoogan JM. Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648. PMID: 32091533.
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo Q, Ji R, Wang H, Wang Y, Zhou Y. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020 May;94:91-95. doi: 10.1016/j.ijid.2020.03.017. Epub 2020 Mar 12. PMID: 32173574; PMCID: PMC7194638.
Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, Huang H, Zhang L, Zhou X, Du C, Zhang Y, Song J, Wang S, Chao Y, Yang Z, Xu J, Zhou X, Chen D, Xiong W, Xu L, Zhou F, Jiang J, Bai C, Zheng J, Song Y. Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994. Erratum in: JAMA Intern Med. 2020 Jul 1;180(7):1031. PMID: 32167524; PMCID: PMC7070509.
Nugraha PK, Kusuma E, Sulistiawan SS, Husain TA. Comorbidities as Risk Factors for Mortality in COVID-19 Acute Respiratory Distress Syndrome Adult Patients: A Single-Center Retrospective Study. IJSCIA. 2021; 2(6): 979-84. https://www.ijscia.com/wp-content/uploads/2021/12/Volume2-Issue6-Nov-Dec-No.199-979-984.pdf
Blomberg B, Mohn KG, Brokstad KA, Zhou F, Linchausen DW, Hansen BA, Lartey S, Onyango TB, Kuwelker K, Sævik M, Bartsch H, Tøndel C, Kittang BR; Bergen COVID-19 Research Group; Cox RJ, Langeland N. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021 Sep;27(9):1607-1613. doi: 10.1038/s41591-021-01433-3. Epub 2021 Jun 23. PMID: 34163090; PMCID: PMC8440190.
Nandí-Lozano E, Espinosa LE, Viñas-Flores L, Avila-Figueroa C. Acute respiratory infection in children who go to a child development center. Salud Publica Mex. 2022; 44:201-6. https://www.scielosp.org/article/spm/2002.v44n3/201-206/es/
Cauthen DB. Family practice incidence rates. J Am Board Fam Pract. 1994 Jul-Aug;7(4):303-9. PMID: 7942099.
Rey Calero J. Epidemiological method and community health. Madrid: Interamericana. McGraw-Hill. 1989.
Turabian JL. Complications Originated as a Consequence of the Acute Infection of COVID-19 or the Treatments Performed. Case Series in General Medicine from March 15, 2020 to October 31, 2022, in Toledo, Spain. Medp Public Health Epidemiol. 2023; 2(1): mpphe–202301001. http://medpresspublications.com/articles/mpphe/mpphe-202301001.pdf
Pacheco Campos L, Dávila Aliaga C, Espinola Sánchez M. Factors associated with complications from COVID-19 in hospital workers: A retrospective cohort study. Medwave. 2022 Oct 4;22(9):e2536. English, Spanish. doi: 10.5867/medwave.2022.09.2536. PMID: 36201108.
Huang Y, Pinto MD, Borelli JL, Asgari Mehrabadi M, Abrahim HL, Dutt N, Lambert N, Nurmi EL, Chakraborty R, Rahmani AM, Downs CA. COVID Symptoms, Symptom Clusters, and Predictors for Becoming a Long-Hauler Looking for Clarity in the Haze of the Pandemic. Clin Nurs Res. 2022 Nov;31(8):1390-1398. doi: 10.1177/10547738221125632. Epub 2022 Sep 24. PMID: 36154716; PMCID: PMC9510954.
Montenegro P, Brotons C, Serrano J, Fernández D, Garcia-Ramos C, Ichazo B, Lemaire J, Moral I, Wienese RP, Pitarch M, Puig M, Vilella MT, Sellarès J. Community seroprevalence of COVID-19 in probable and possible cases at primary health care centres in Spain. Fam Pract. 2021 Mar 29;38(2):154-159. doi: 10.1093/fampra/cmaa096. PMID: 32914857; PMCID: PMC7797756.
Charles III Institute of Health. Strategy for early detection, surveillance and control of COVID-1 Updated December 22, Ministry of Health. Spain. 2020; https://www.mscbs.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Estrategia_vigilancia_y_control_e_indicadores.pdf
Turabian JL. An ostrich strategy for covid-19 is too risky. BMJ. 2022 May 3;377:o1112. doi: 10.1136/bmj.o1112. PMID: 35504630.
Turabian JL. COVID-19 Breakthrough Infections In Vaccinated People With Vaccine Booster In 2022 Versus Covid-19 Cases In Unvaccinated People In 2020: A New Disease Whose Clinic We Should Know Or Another Cause Of The Old Symptoms Of The Common Cold? J General medicine and Clinical Practice. 2022; 5(2). https://www.auctoresonline.org/uploads/articles/1655371786Covid__1_.pdf
Turabian JL. Secondary infections in the family from primary cases of covid-19 breakthrough infections in fully vaccinated or not fully vaccinated people. Two doses modestly reduce family transmission but does not eliminate it. Journal of SARS-CoV-2 Research. 2022; 2: 12-24. https://doi.org/10.36013/sarc-cov-2.v2i.85
Turabian JL. Risk Factors and Incidence Rates of Covid-19 Breakthrough Infections in Vaccinated People in General Medicine Practice in Toledo (Spain). Arch Fam Med Gen Pract. 2022; 7(1):183-92. https://scholars.direct/Articles/family-medicine/afmgp-7-033.pdf?jid=family-medicine
Turabian JL. Incidence Rates and Risk Factors of Covid-19 Reinfections from March 1, 2020 To July 1, 2022 in A General Medicine office in Toledo, Spain. Ann Community Med Prim Health Care. 2022; 1(1): 1006. https://meddocsonline.org/annals-of-community-medicine-and-primary-health-care/incidence-rates-and-risk-factors-of-covid-19-reinfections-from-March-1-2020-to-july-1-2022-in-a-general-medicine-office-in-toledo-spain.pdf
Strauss AL. Chronic illness and the quality of life. St Louis: The C.V. Mosby Company. 1984.
WHO. International Statistical Classification of Diseases and Health-Related Problems. ICD-10 Version: 2019. https://icd.who.int/browse10/2019/en
Mao S, Huang T, Yuan H, Li M, Huang X, Yang C, Zhou X, Cheng X, Su Q, Wu X. Epidemiological analysis of 67 local COVID-19 clusters in Sichuan Province, China. BMC Public Health. 2020 Oct 8;20(1):1525. doi: 10.1186/s12889-020-09606-4. PMID: 33032575; PMCID: PMC7543676.
Reijneveld SA. Age in epidemiological analysis. J Epidemiol Community Health. 2003 Jun;57(6):397. doi: 10.1136/jech.57.6.397. PMID: 12775780; PMCID: PMC1732463.
Reijneveld SA, Gunning-Schepers LJ. Age, socioeconomic status, and mortality at the aggregate level. J Epidemiol Community Health. 1994 Apr;48(2):146-50. doi: 10.1136/jech.48.2.146. PMID: 8189168; PMCID: PMC1059923.
Díez-Fuertes F, Iglesias-Caballero M, García-Pérez J, Monzón S, Jiménez P, Varona S, Cuesta I, Zaballos Á, Jiménez M, Checa L, Pozo F, Pérez-Olmeda M, Thomson MM, Alcamí J, Casas I. A Founder Effect Led Early SARS-CoV-2 Transmission in Spain. J Virol. 2021 Jan 13;95(3):e01583-20. doi: 10.1128/JVI.01583-20. PMID: 33127745; PMCID: PMC7925114.
López MG, Chiner-Oms Á, García de Viedma D, Ruiz-Rodriguez P, Bracho MA, Cancino-Muñoz I, D'Auria G, de Marco G, García-González N, Goig GA, Gómez-Navarro I, Jiménez-Serrano S, Martinez-Priego L, Ruiz-Hueso P, Ruiz-Roldán L, Torres-Puente M, Alberola J, Albert E, Aranzamendi Zaldumbide M, Bea-Escudero MP, Boga JA, Bordoy AE, Canut-Blasco A, Carvajal A, Cilla Eguiluz G, Cordón Rodríguez ML, Costa-Alcalde JJ, de Toro M, de Toro Peinado I, Del Pozo JL, Duchêne S, Fernández-Pinero J, Fuster Escrivá B, Gimeno Cardona C, González Galán V, Gonzalo Jiménez N, Hernáez Crespo S, Herranz M, Lepe JA, López-Causapé C, López-Hontangas JL, Martín V, Martró E, Milagro Beamonte A, Montes Ros M, Moreno-Muñoz R, Navarro D, Navarro-Marí JM, Not A, Oliver A, Palop-Borrás B, Parra Grande M, Pedrosa-Corral I, Pérez González MC, Pérez-Lago L, Pérez-Ruiz M, Piñeiro Vázquez L, Rabella N, Rezusta A, Robles Fonseca L, Rodríguez-Villodres Á, Sanbonmatsu-Gámez S, Sicilia J, Soriano A, Tirado Balaguer MD, Torres I, Tristancho A, Marimón JM; SeqCOVID-Spain consortium; Coscolla M, González-Candelas F, Comas I. The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant. Nat Genet. 2021 Oct;53(10):1405-1414. doi: 10.1038/s41588-021-00936-6. Epub 2021 Sep 30. PMID: 34594042; PMCID: PMC8481935.
Hodcroft EB, Zuber M, Nadeau S, Vaughan TG, Crawford KHD, Althaus CL, Reichmuth ML, Bowen JE, Walls AC, Corti D, Bloom JD, Veesler D, Mateo D, Hernando A, Comas I, González-Candelas F; SeqCOVID-SPAIN consortium; Stadler T, Neher RA. Spread of a SARS-CoV-2 variant through Europe in the summer of 2020. Nature. 2021 Jul;595(7869):707-712. doi: 10.1038/s41586-021-03677-y. Epub 2021 Jun 7. PMID: 34098568.
Coordination Center for Health Alerts and Emergencies (2021) [Update on the epidemiological situation of variant B.1.1.7 of SARS-CoV-2 and other variants of interest]. Ministry of Health. Government of Spain. https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/20210208_Variantes_de_SARS-CoV-2_en_Espana.pdf
García Marín AM, Chiner Oms A, González Candelas F, Comas Espadas I, López MG, Coscolla Devis M. What genomic epidemiology teaches us about the waves of COVID-19 in Spain (and how to avoid a new wave).2021. https://theconversation.com/lo-que-nos-ensena-la-epidemiologia-genomica-sobre-las-olas-de-covid-19-en-espana-y-como-evitar-una-nueva-ola-155401
Rapid Risk Assessment. SARS-CoV-2 variants in Spain: Ómicron lineages BA.2.12.1, BA.4 and BA.5 11th update, June 28, 2022. 2022. Health Alerts and Emergencies Coordination Center. Ministry of Health. Spain. https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/20220628-ERR.pdf
Health Alerts and Emergencies Coordination Center. Update of the epidemiological situation of SARS-CoV-2 variants in Spain. May 17, 2022. Ministry of Health. Spain. https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Actualizacion_variantes_20220517.pdf
Health Alerts and Emergencies Coordination Center. Update on the epidemiological situation of SARS-CoV-2 variants in Spain. 2022. Ministry of Health. Spain. https://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/COVID19_Actualizacion_variantes_20221017.pdf
Emergency Situational Updates. Weekly epidemiological update on COVID-19 - 21 December 2022. Edition 123. WHO; 21 December 2022. https://www.who.int/publications/m/item/covid-19-weekly-epidemiological-update---21-december-2022
Greenhalgh T, Sivan M, Delaney B, Evans R, Milne R. Long covid-an update for primary care. BMJ. 2022 Sep 22;378:e072117. doi: 10.1136/bmj-2022-072117. PMID: 36137612.
WHO. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1
Frellick. When is COVID-19 not persistent, but intermediate?. Medscape. 2022. https://espanol.medscape.com/verarticulo/5908984
Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV; WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022 Apr;22(4):e102-e107. doi: 10.1016/S1473-3099(21)00703-9. Epub 2021 Dec 21. PMID: 34951953; PMCID: PMC8691845.
Oliva-Sánchez PF, Vadillo-Ortega F, Bojalil-Parra R, Martínez-Kobeh JP, Pérez-Pérez JR, Pérez-Avalos JL. Factores de riesgo para complicaciones graves de COVID-19, comparando tres olas epidemiológicas. Un enfoque desde la atención primaria en México [Risk factors for COVID-19 severe complications comparing three major epidemiological waves: An approach from primary health care in Mexico]. Aten Primaria. 2022 Nov;54(11):102469. Spanish. doi: 10.1016/j.aprim.2022.102469. Epub 2022 Sep 13. PMID: 36244180; PMCID: PMC9468309.
Mayo Clinic Staff. COVID-19: Who's at higher risk of serious symptoms? Mayo Clinic. 2022. https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-who-is-at-risk/art-20483301
Reilev M, Kristensen KB, Pottegård A, Lund LC, Hallas J, Ernst MT, Christiansen CF, Sørensen HT, Johansen NB, Brun NC, Voldstedlund M, Støvring H, Thomsen MK, Christensen S, Gubbels S, Krause TG, Mølbak K, Thomsen RW. Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020 Oct 1;49(5):1468-1481. doi: 10.1093/ije/dyaa140. PMID: 32887982; PMCID: PMC7499657.
Nie Y, Li J, Huang X, Guo W, Zhang X, Ma Y, Wang H, Qi M, Tang X, Shen X, Dai X. Epidemiological and clinical characteristics of 671 COVID-19 patients in Henan Province, China. Int J Epidemiol. 2020 Aug 1;49(4):1085-1095. doi: 10.1093/ije/dyaa081. PMID: 32588051; PMCID: PMC7337875.
Ortiz-Brizuela E, Villanueva-Reza M, González-Lara MF, Tamez-Torres KM, Román-Montes CM, Díaz-Mejía BA, Pérez-García E, Olivas-Martínez A, Rajme-López S, Martinez-Guerra BA, de-León-Cividanes NA, Fernández-García OA, Guerrero-Torres L, Torres-González L, Carrera-Patiño FA, Corral-Herrera EA, Hernández-Alemón AN, Tovar-Vargas MLÁ, Serrano-Pinto YG, Espejo-Ortiz CE, Morales-Ortega ML, Lozano-Cruz ÓA, Cárdenas-Fragoso JL, Vidal-Mayo JJ, Hernández-Gilsoul T, Rivero-Sigarroa E, Domínguez-Cherit G, Cervantes-Villar LE, Ramos-Cervantes MDP, Ibarra-González V, Calva-Mercado JJ, Sierra-Madero JG, López-Íñiguez Á, Ochoa-Hein E, Crabtree-Ramírez BE, Galindo-Fraga A, Guerrero-Almeida ML, Ruiz-Palacios GM, Gulías-Herrero A, Sifuentes-Osornio J, Kershenobich-Stalnikowitz D, Ponce-de-León A. CLINICAL AND EPIDEMIOLOGICAL CHARACTERISTICS OF PATIENTS DIAGNOSED WITH COVID-19 IN A TERTIARY CARE CENTER IN MEXICO CITY: A PROSPECTIVE COHORT STUDY. Rev Invest Clin. 2020;72(3):165-177. doi: 10.24875/RIC.20000211. Erratum in: Rev Invest Clin. 2020;72(4):252-258. PMID: 32584326.
Pérez-Sastré MA, Valdés J, Ortiz-Hernández L. Clinical characteristics and severity of COVID-19 among Mexican adults. Gac Med Mex. 2020;156(5):373-381. English. doi: 10.24875/GMM.M20000424. PMID: 33372930.
Hernández-Ávila M, Vieyra-Romero W, Gutiérrez-Díaz H, Barros-Sierra D, Zepeda R, Segura-Sánchez C, Velasco R, Ramírez EA, Tamayo-Ortiz M, Borja-Aburto V, Rascón-Pacheco A, Barrientos-Gutiérrez T, Ortega-Álvarez M. Comportamiento epidemiológico de SARS-CoV-2 en población trabajadora afiliada al Instituto Mexicano del Seguro Social. Salud Publica Mex. 2021 Sep 3;63(5):607-618. Spanish. doi: 10.21149/12495. PMID: 35099882.
Ioannou GN, Locke E, Green P, Berry K, O'Hare AM, Shah JA, Crothers K, Eastment MC, Dominitz JA, Fan VS. Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection. JAMA Netw Open. 2020 Sep 1;3(9):e2022310. doi: 10.1001/jamanetworkopen.2020.22310. PMID: 32965502; PMCID: PMC7512055.
Zhang H, Wu Y, He Y, Liu X, Liu M, Tang Y, Li X, Yang G, Liang G, Xu S, Wang M, Wang W. Age-Related Risk Factors and Complications of Patients With COVID-19: A Population-Based Retrospective Study. Front Med (Lausanne). 2022 Jan 11;8:757459. doi: 10.3389/fmed.2021.757459. PMID: 35087843; PMCID: PMC8786909.
Health Alerts and Emergencies Coordination Center. Scientific-Technical Information Coronavirus disease, COVID-19 Update, January 15, 2021. Ministry of Health. Spainhttps://www.sanidad.gob.es/profesionales/saludPublica/ccayes/alertasActual/nCov/documentos/ITCoronavirus.pdf
Anonymous. Who are the people at risk of COVID?. Medical Writing.https://www.redaccionmedica.com/recursos-salud/faqs-covid19/cuales-son-las-personas-de-riesgo-del-covid
CDC (2022) Factors That Affect Your Risk of Getting Very Sick from COVID-19. Updated Oct. 19, 2022. Last Updated Oct. 19, 2022. National Center for Immunization and Respiratory Diseases (NCIRD), Division of Viral Diseases. https://www.cdc.gov/coronavirus/2019-ncov/your-health/risks-getting-very-sick.html
Nania R. How chronic illnesses complicate coronavirus infections. Diabetes and heart disease increase the risk of the country's population becoming seriously ill from COVID-19. AARP. 2020. https://www.aarp.org/espanol/salud/enfermedades-y-tratamientos/info-2020/condiciones-cronicas-complican-infecciones-por-coronavirus.html
Gupta A, Madhavan MV, Sehgal K, Nair N, Mahajan S, Sehrawat TS, Bikdeli B, Ahluwalia N, Ausiello JC, Wan EY, Freedberg DE, Kirtane AJ, Parikh SA, Maurer MS, Nordvig AS, Accili D, Bathon JM, Mohan S, Bauer KA, Leon MB, Krumholz HM, Uriel N, Mehra MR, Elkind MSV, Stone GW, Schwartz A, Ho DD, Bilezikian JP, Landry DW. Extrapulmonary manifestations of COVID-19. Nat Med. 2020 Jul;26(7):1017-1032. doi: 10.1038/s41591-020-0968-3. Epub 2020 Jul 10. PMID: 32651579.
Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW; the Northwell COVID-19 Research Consortium; Barnaby DP, Becker LB, Chelico JD, Cohen SL, Cookingham J, Coppa K, Diefenbach MA, Dominello AJ, Duer-Hefele J, Falzon L, Gitlin J, Hajizadeh N, Harvin TG, Hirschwerk DA, Kim EJ, Kozel ZM, Marrast LM, Mogavero JN, Osorio GA, Qiu M, Zanos TP. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775. Erratum in: JAMA. 2020 May 26;323(20):2098. PMID: 32320003; PMCID: PMC7177629.
Bello-Chavolla O, Bahena-López J, Antonio-Villa N. Predicting Mortality Due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 Outcomes in México. J Clin Endocrinol Metab. 2020; 105:1–10. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7313944/
Chudzik M, Kapusta J. Cardiovascular Complications of Long COVID-19: Prevalence, Diagnosis, and Risk Factors. 10.1007/978-3-031-15478-2. In book: Cardiovascular Complications of COVID-19. 2023; 379-400. https://link.springer.com/chapter/10.1007/978-3-031-15478-2_23